We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FFH:TSXFairfax Financial Holdings Limited Analysis

Data as of 2026-06-07 - not real-time

CA$2,220.71

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Fairfax Financial (FFH) trades around CAD 2,220, nearly double its discounted cash‑flow fair value of about CAD 1,192, indicating a significant premium. The stock’s trailing P/E of 7.9 is well below the industry average of 17, suggesting relative cheapness on earnings, while the forward P/E of 10 remains modest. Margins are solid (gross ~43%, operating ~14%) and free cash flow exceeds CAD 2.4 bn, supporting the recently declared preferred dividend of $0.315 per share and a low payout ratio of roughly 7%. Technically, the price sits below the 20‑, 50‑ and 200‑day SMAs, the 30‑day volatility is high at 32%, but the beta is only 0.16, indicating limited market‑beta exposure.
The company announced a senior notes offering of US$750 m and a preferred dividend, underscoring confidence in its balance‑sheet strength despite a 7.8% revenue decline. With a modest debt‑to‑equity of 45.8% and a strong ROE of 17%, the fundamentals are resilient, yet the current market premium and bearish trend signal caution. Overall, FFH appears financially sound but may be priced for optimism, warranting a measured stance.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price well above DCF fair value
  • Bearish technical positioning (below SMAs, support near 2,066)
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Attractive earnings multiple versus peers
  • Strong cash generation and low payout ratio
  • Increasing volume indicating renewed investor interest

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Solid ROE and operating margins
  • Sustainable dividend supported by free cash flow
  • Diversified global insurance and investment platform

Key Metrics & Analysis

Financial Health

Revenue Growth-7.80%
Profit Margin11.72%
P/E Ratio7.9
ROE17.22%
ROA4.34%
Debt/Equity45.82
P/B Ratio1.3
Op. Cash FlowCA$1.5B
Free Cash FlowCA$2.4B
Industry P/E17.0

Technical Analysis

TrendBearish
RSI49.2
SupportCA$2,066.16
ResistanceCA$2,286.85
MA 20CA$2,202.92
MA 50CA$2,297.90
MA 200CA$2,361.41
MACDBullish
VolumeIncreasing
Fear & Greed Index83.02

Valuation

Fair ValueCA$1,191.93
Target PriceCA$2,783.58
Upside/Downside25.35%
GradeOvervalued
TypeValue
Dividend Yield0.94%

Risk Assessment

Beta0.16
Volatility32.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.